DaVita Inc. Stock

Equities

DVA

US23918K1088

Healthcare Facilities & Services

Market Closed - Nyse 16:00:02 2024-05-22 EDT 5-day change 1st Jan Change
134.8 USD -2.84% Intraday chart for DaVita Inc. -1.65% +28.63%
Sales 2024 * 12.68B 17.36B Sales 2025 * 13.21B 18.09B Capitalization 12.16B 16.65B
Net income 2024 * 775M 1.06B Net income 2025 * 811M 1.11B EV / Sales 2024 * 1.77 x
Net Debt 2024 * 10.33B 14.14B Net Debt 2025 * 10.49B 14.35B EV / Sales 2025 * 1.71 x
P/E ratio 2024 *
15.6 x
P/E ratio 2025 *
13.8 x
Employees 70,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 53.55%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.84%
1 week-1.65%
Current month-3.06%
1 month+5.42%
3 months+11.46%
6 months+38.13%
Current year+28.63%
More quotes
1 week
134.73
Extreme 134.73
141.44
1 month
130.96
Extreme 130.96
145.04
Current year
103.40
Extreme 103.4
145.04
1 year
71.51
Extreme 71.51
145.04
3 years
65.28
Extreme 65.28
145.04
5 years
43.40
Extreme 43.4
145.04
10 years
43.40
Extreme 43.4
145.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 97-12-31
Director of Finance/CFO 59 17-02-26
Chief Tech/Sci/R&D Officer - 19-11-30
Members of the board TitleAgeSince
Director/Board Member 76 00-10-31
Director/Board Member 71 15-10-07
Director/Board Member 66 16-07-10
More insiders
Date Price Change Volume
24-05-22 134.8 -2.84% 933,663
24-05-21 138.7 -1.59% 687,379
24-05-20 140.9 +0.79% 827,249
24-05-17 139.8 +2.45% 758,649
24-05-16 136.5 -1.02% 603,039

Delayed Quote Nyse, May 22, 2024 at 04:00 pm

More quotes
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad; - other (4.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
134.8 USD
Average target price
142.2 USD
Spread / Average Target
+5.52%
Consensus